Mr David Hrouda
MB BS MD FRCS (Urol)
Title: Consultant Urologist
Specialty 1: Urology
Specialty 1 Specialisation: Laparoscopic, robotic and cancer surgery
Clinical Interests: Laparoscopic and robotic renal surgery, bladder cancer surgery and general urology
Pen Picture: I am a Urological Oncology Surgeon based at Imperial college Healthcare NHS Trust. I introduced laparoscopic total and partial nephrectomy into my trust 7 years ago and now have one of the biggest laparoscopic renal surgery practices in the United Kingdom. For the last 7 years I have routinely performed large numbers of radical cystectomies. Initially, an open radical prostatectomy surgeon, I have helped to develop robotic prostatectomy at Imperial and I also perform robotic partial nephrectomy for cancer of the kidney. I am the Lead Clinician in Urology for Imperial Healthcare NHS Trust. I am the Chair of the West London Urology Tumour Working Group. I am Chair of the Imperial Urological Cancer Specialist Multidisciplinary team..
Languages Spoken: English
Regular Cromwell Clinics: No
Telephone Number: 020 7460 5700
Clinic days:
Mon
:
Tue
:
Wed
:
Thurs
:
Fri
:
Sat
:
Year Qualified: 1989
Memberships: General Medical Council Full Registration, Specialist Registration in Urology, Medical Defence Union, Fellow of the Royal College of Surgeons of England, British Association of Urological Surgeons,
European Association of Urology, British Medical Association,
Royal Society of Medicine (Member of Urology, Surgery Representative Oncology Section)
NHS Hospital: Invalid
Additional Posts: West Middlesex University Hospital
Research Interests:
Published Papers: • Gene Therapy for Prostate Cancer. Hrouda D, Perry MJA, Dalgleish AG. Seminars in Oncology 1999; 26:455-471
• Allogeneic Whole Tumour Cell Vaccination in the Rat Model of Prostate Cancer. Hrouda D, Todryk SM, Perry MJA, Souberbielle BE, Kayaga J, Kirby RS, Dalgleish AG. BJU International 2000; 86: 742-748
• Genetic Factors In Chemically-Induced Transitional Cell Bladder Cancer. Filiadis I & Hrouda D. BJU International 2000; 86: 794-801
• The Immunotherapy of Prostate Cancer. Dalgleish AG, Perry MJA, Eaton JD, Hrouda D, Todryk SM, Kirby RS. Prostate Cancer and Prostatic Diseases 2000; 3: 303-307
• Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. Winkler M, Hrouda D and Christmas TJ. BJU Int. 2007 Mar;99(3):554-8